Sevoflurane and Gastroesophageal reflux disease - a phase IV clinical study of FDA data
Summary:
Gastroesophageal reflux disease is found among people who take Sevoflurane, especially for people who are male, 10-19 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Sevoflurane and have Gastroesophageal reflux disease. It is created by eHealthMe based on reports of 8,466 people who have side effects when taking Sevoflurane from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
8,466 people reported to have side effects when taking Sevoflurane.
Among them, 12 people (0.14%) have Gastroesophageal reflux disease.
What is Sevoflurane?
Sevoflurane has active ingredients of sevoflurane. eHealthMe is studying from 8,477 Sevoflurane users for its effectiveness, alternative drugs and more.
What is Gastroesophageal reflux disease?
Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus) is found to be associated with 3,734 drugs and 3,293 conditions by eHealthMe.
Number of Sevoflurane and Gastroesophageal reflux disease reports submitted per year:

Time on Sevoflurane when people have Gastroesophageal reflux disease *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Gastroesophageal reflux disease when taking Sevoflurane *:
- female: 0.0 %
- male: 100 %
Age of people who have Gastroesophageal reflux disease when taking Sevoflurane *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 90 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 10 %
- 60+: 0.0 %
Common drugs people take besides Sevoflurane *:
- Propofol: 10 people, 83.33%
- Versed: 9 people, 75.00%
- Sublimaze: 9 people, 75.00%
- Accutane: 9 people, 75.00%
- Vicodin: 6 people, 50.00%
- Ropivacaine Hydrochloride: 1 person, 8.33%
- Rocuronium Bromide: 1 person, 8.33%
- Nexium: 1 person, 8.33%
- Flurbiprofen: 1 person, 8.33%
- Fentanyl: 1 person, 8.33%
Common side effects people have besides Gastroesophageal reflux disease *:
- Fatigue (feeling of tiredness): 10 people, 83.33%
- Fever: 10 people, 83.33%
- Back Pain: 10 people, 83.33%
- Weakness: 10 people, 83.33%
- Respiratory Rate Decreased (less breathing rate/min): 9 people, 75.00%
- Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 9 people, 75.00%
- High Blood Pressure: 9 people, 75.00%
- Hyperventilation: 9 people, 75.00%
- Movement - Uncontrolled Or Slow: 9 people, 75.00%
- Nausea (feeling of having an urge to vomit): 9 people, 75.00%
Common conditions people have *:
- Sedation: 2 people, 16.67%
- Pain: 1 person, 8.33%
- Neuralgia (pain in one or more nerves): 1 person, 8.33%
- Local Anaesthesia: 1 person, 8.33%
- Hypotension (abnormally low blood pressure): 1 person, 8.33%
- General Anaesthesia: 1 person, 8.33%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
- Anaesthesia: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Sevoflurane and have Gastroesophageal reflux disease?
Check whether Gastroesophageal reflux disease is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Gastroesophageal reflux disease and when was it recovered:
Expand to all the drugs that have ingredients of sevoflurane:
Alternative drugs to, pros and cons of Sevoflurane:
- Sevoflurane (8,477 reports)
Common Sevoflurane side effects:
- Hypotension (abnormally low blood pressure): 871 reports
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 476 reports
- Bradycardia (abnormally slow heart action): 450 reports
- Arrhythmias (irregular heartbeat): 419 reports
- Fever: 323 reports
- Drug ineffective: 279 reports
Browse all side effects of Sevoflurane:
a b c d e f g h i j k l m n o p q r s t u v w x y zGastroesophageal reflux disease treatments and more:
- Gastroesophageal reflux disease (399,856 reports)
COVID vaccines that are related to Gastroesophageal reflux disease:
- Gastroesophageal reflux disease in Moderna COVID Vaccine
- Gastroesophageal reflux disease in Pfizer BioNTech Covid Vaccine
- Gastroesophageal reflux disease in Johnson and Johnson Covid Vaccine
Common drugs associated with Gastroesophageal reflux disease:
- Nexium: 11,578 reports
- Fosamax: 6,886 reports
- Prednisone: 6,698 reports
- Prilosec: 6,647 reports
- Aspirin: 6,614 reports
- Omeprazole: 6,286 reports
- Protonix: 4,609 reports
- Prevacid: 4,493 reports
- Vioxx: 4,383 reports
- Pantoprazole: 4,311 reports
All the drugs that are associated with Gastroesophageal reflux disease:
- Gastroesophageal reflux disease (3,734 drugs)
Common conditions associated with Gastroesophageal reflux disease:
- High blood pressure: 8,283 reports
- Osteoporosis: 6,304 reports
- Pain: 4,963 reports
All the conditions that are associated with Gastroesophageal reflux disease:
- Gastroesophageal reflux disease (3,293 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sevoflurane (the active ingredients of Sevoflurane) and Sevoflurane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Itraconazole and Subcutaneous Emphysema - 4 seconds ago
- Loraz and Urine Sodium Increased - 8 seconds ago
- Synthroid and Regressive Behavior - 14 seconds ago
- Benztropine Mesylate and Provera drug interaction - 22 seconds ago
- Celestone and Marcaine drug interaction - 24 seconds ago
- Compazine and Infective Pulmonary Exacerbation Of Cystic Fibrosis - 25 seconds ago
- Activella and Topicort drug interaction - 31 seconds ago
- Singulair and Faecal Incontinence - 32 seconds ago
- Vidaza and Bruxism Aggravated - 33 seconds ago
- Invanz and Respiratory Acidosis - 37 seconds ago